Difference between revisions of "Fluorouracil (5-FU)"
Warner-admin (talk | contribs) m (Text replacement - " - obsolete" to "_-_historical") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
||
Line 126: | Line 126: | ||
<references/> | <references/> | ||
− | [[Category: | + | [[Category:Drugs]] |
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Topical medications]] | [[Category:Topical medications]] |
Revision as of 22:12, 13 June 2018
General information
Class/mechanism: Pyrimidine analog, antimetabolite, inhibitor of thymidylate synthase. Metabolized to 5-fluoro-2'-deoxyuridine monophosphate (FdUMP) and 5-fluorouridine triphosphate (FUTP). FdUMP inhibits DNA synthesis by binding to thymidylate synthase and inhibiting production of thymidylate; FUTP interferes with RNA processing when it is mistakenly incorporated in place of uridine triphosphate (UTP).[1][2].
Route: IV
Extravasation: irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Anal cancer
- Bladder cancer
- Breast cancer
- Cervical cancer
- Cholangiocarcinoma
- Colon cancer
- Esophageal cancer
- Gastric cancer
- Head and neck cancer
- Hepatocellular carcinoma
- Nasopharyngeal carcinoma
- Pancreatic cancer
- Pancreatic NET
- Penile cancer
- Prostate cancer
- Rectal cancer
- SCC of unknown primary
Diseases for which it was used
Patient drug information
- Fluorouracil (5-FU) patient drug information (Chemocare)[3]
- Fluorouracil (5-FU) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 4/25/1962: Initial FDA approval
Also known as
- Generic names: 5 Fluorouracil, 5 FU, 5-fluoracilo, 5-fluorouracilo, 5-fluorouracyl, FU
- Brand names:
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Accusite | Actino Hermal | Adrucil | Arumel | Benton | Biofur | Carac | Carebin |
Carzonal | Cinco-FU | Cinkef-U | Curacil | Effcil | Efudex | Efurix | Ezadex |
Fauldfluor | Fivocil | Fivoflu | Flacule | Flonida | Florac | Fluhomer | Fluolex |
Fluoroplex | Fluor-Uracil | Fluoro-Uracile ICN | Fluoro-Uracil ICN | Fluorouracile | Fluorouracilo | Fluorourcil | Fluoruracilo |
Fluoxan | Flurablastin | Flurac | Fluracedyl | Fluracil | Fluroblastin | Fluroblastine | Ftoruracil |
Ftouracil | Haemato-FU | Ifacil | Kang Ning | Kecimeton Tatumi | Killit | Lunachol | Lunapon |
Natira U | Neofluor | O Fluor | Oncofu | Onkofluor | Pentafu | Pharmauracil | Phthoruracil |
Phtoruracil | Ribofluor | Rotianin | Satelol | Seco Uracil | Tecflu | Timadin | Triosules |
Uflahex | Ulosagen | Ulup | Uraciflor | Utoral | Vaflu | Vafu |
References
- Drugs
- Intravenous medications
- Topical medications
- Irritant chemotherapy
- Fluoropyrimidines
- Anal cancer medications
- Bladder cancer medications
- Breast cancer medications
- Cervical cancer medications
- Cholangiocarcinoma medications
- Colon cancer medications
- Esophageal cancer medications
- Gastric cancer medications
- Head and neck cancer medications
- Hepatocellular carcinoma medications
- Nasopharyngeal carcinoma medications
- Pancreatic cancer medications
- Pancreatic NET medications
- Penile cancer medications
- Prostate cancer medications
- Rectal cancer medications
- SCC of unknown primary medications
- Drugs FDA approved in 1962
- WHO Essential Cancer Medicine